{"public_id":"cl_77f00bc6ab17db90eebabab90a0fb05d","status":"active","superseded_by_public_id":null,"corpus_id":34127875,"text":"In episodes without confirmed infection, antibiotics were stopped after 72–96 hours, with a median treatment duration of three days and 100% survival.","confidence":0.94,"paper":{"corpus_id":34127875,"title":"Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination","url":"https://sah.borca.ai/papers/34127875"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.94,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_38d5e42967305fc85fd45a38d1d76bce","name":"confirmed infection","description":"An episode in which microbiological or clinical evidence supports the presence of infection.","types":["diagnostic status"],"url":"https://sah.borca.ai/concepts/co_38d5e42967305fc85fd45a38d1d76bce"},{"public_id":"co_5c58e078b1789934463250e03331c34b","name":"survival rate","description":"The proportion of episodes or patients who survived the observed treatment period.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_5c58e078b1789934463250e03331c34b"},{"public_id":"co_d55bbaf2d85c0cb2dede78b0ae8543ab","name":"antibiotics","description":"Drugs used to treat bacterial infection in the febrile neutropenic episodes described.","types":["drug class"],"url":"https://sah.borca.ai/concepts/co_d55bbaf2d85c0cb2dede78b0ae8543ab"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_77f00bc6ab17db90eebabab90a0fb05d"}